The effect on intraocular pressure of latanoprost once or four times daily
Author:
Open Access
- 1 October 2001
- journal article
- clinical trial
- Published by BMJ in British Journal of Ophthalmology
- Vol. 85 (10) , 1163-1166
Abstract
To compare the effect on intraocular pressure (IOP) of latanoprost applied once daily with four times daily and to study if the difference persisted when treatment changed to once daily. IOP was followed in 28 healthy volunteers in a double masked randomised 52 day study. Latanoprost 50 microg/ml was administered once daily in one eye and four times daily in the other during 2 weeks. Subsequently both eyes received one daily drop for 2 weeks. After another 3 weeks without treatment, a single drop was instilled in each eye. The IOP reduction on days 2 and 3 was greater in the eyes treated with four daily doses (p<0.01). During the following period there were no statistically significant differences between the eyes. After 3 weeks without treatment the IOP was lower than pretreatment (p<0.001). A single dose of latanoprost on day 50 resulted in a similar decrease in IOP in both eyes. Transient photophobia, mild flare, and/or a few cells occurred in 15 subjects. Two subjects were withdrawn because of photophobia and/or signs of anterior uveitis. Latanoprost four times daily caused an IOP reducing effect which was similar to once daily dosing, except for the first 2 days of treatment when it was more effective. Transient photophobia, cells, and flare were common during the four dose regimen, but resolved spontaneously without cessation of treatment.Keywords
This publication has 18 references indexed in Scilit:
- Effect of Latanoprost on the Extracellular Matrix of the Ciliary Muscle. A Study on Cultured Cells and Tissue SectionsExperimental Eye Research, 1998
- Cystoid macular edema and anterior uveitis associated with latanoprost useOphthalmology, 1998
- Latanoprost twice daily is less effective than once daily: indication of receptor subsensitivity?Current Eye Research, 1998
- Latanoprost administered once daily caused a maintained reduction of intraocular pressure in glaucoma patients treated concomitantly with timolol.British Journal of Ophthalmology, 1995
- Effects of PhXA41, A New Prostaglandin F2α Analog, on Aqueous Humor Dynamics in Human EyesOphthalmology, 1993
- Intraocular Pressure-reducing Effect of PhXA41 in Patients with Increased Eye PressureOphthalmology, 1993
- Intraocular Pressure-reducing Effect of PhXA41 in Ocular HypertensionOphthalmology, 1993
- Intraocular Pressure Reduction With PhXA34, a New Prostaglandin Analogue, in Patients With Ocular HypertensionArchives of Ophthalmology (1950), 1992
- Morphological study of the anterior segment of cynomolgus monkey eyes following treatment with prostaglandin F2αExperimental Eye Research, 1988
- Effect of Intervals between Doses on the Development of Tolerance to Isosorbide DinitrateNew England Journal of Medicine, 1987